Loading…
Basel Medical Group Ltd is projected to rise to $0.674 by 2027, a +14% move from its current price of $0.5899. BMGL is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $0.567 | $0.5901 | $0.6141 | +0.03% |
| May 30 | $0.5579 | $0.5903 | $0.6245 | +0.06% |
| May 31 | $0.5511 | $0.5904 | $0.6326 | +0.09% |
| Jun 1 | $0.5454 | $0.5906 | $0.6396 | +0.12% |
| Jun 2 | $0.5404 | $0.5908 | $0.6459 | +0.15% |
| Jun 3 | $0.536 | $0.591 | $0.6516 | +0.18% |
| Jun 4 | $0.532 | $0.5912 | $0.6569 | +0.21% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.532 | $0.5912 | $0.6569 | +0.21% |
| Week 2 | $0.5103 | $0.5924 | $0.6877 | +0.43% |
| Week 3 | $0.4946 | $0.5937 | $0.7126 | +0.64% |
| Week 4 | $0.4818 | $0.5949 | $0.7346 | +0.85% |
| Week 5 | $0.471 | $0.5962 | $0.7547 | +1.07% |
| Week 6 | $0.4615 | $0.5975 | $0.7735 | +1.28% |
| Week 7 | $0.453 | $0.5987 | $0.7914 | +1.50% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Basel Medical Group Ltd is a healthcare company that provides general and subspecialized orthopedic services in Singapore, including trauma and sports medicine such as knee/hip replacements, sports medicine/surgery, spine surgery, foot/ankle surgery, and minimally invasive orthopedic procedures, as well as neurosurgical treatments.
The group also offers health screening services, mental health, women's health, and general practice services, with offerings that include consultation, medical diagnosis, and medical and surgical treatments.
The company was incorporated in 2023 and is headquartered in Singapore.
Basel Medical Group Ltd (BMGL) is a healthcare stock trading at $0.5971 per share.
It has a market capitalization of $11.22M and is ranked 5123 by market cap.
The asset sits in the Healthcare sector.
The price outlook is mixed, with near-term bearish indicators reflected in the current technical picture and a longer-term bullish path suggested by the year-by-year forecast. In 2026 the avg price is $0.5971 with neutral sentiment and ROI 0, and the forecast shows stronger upside in subsequent years, including 2027–2050 sectors.
A major floor 26.4% below — a decisive break under it would weaken the trend.
The nearest floor, 5.1% below — buyers have tended to step in here.
The nearest ceiling, 29.5% above — a clean break opens room to run.
A major ceiling 51.7% above — clearing it would confirm fresh momentum.
Key BMGL support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of BMGL market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.6052 | Sell | $0.6062 | Sell |
| MA 10 | $0.6421 | Sell | $0.6295 | Sell |
| MA 20 | $0.6525 | Sell | $0.6402 | Sell |
| MA 50 | $0.6254 | Sell | $0.6439 | Sell |
| MA 100 | $0.6472 | Sell | $0.7522 | Sell |
| MA 200 | $1.07 | Sell | $1.20 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 41.02 | Neutral |
| Stoch RSI (14) | 6.87 | Buy |
| CCI (20) | -67.86 | Neutral |
| Williams %R (14) | -94.57 | Info |
| MACD (12,26,9) | -0.01 | Sell |
| ROC (12) | -22.27 | Sell |
| Bollinger %B (20,2) | 0.28 | Neutral |
| Stochastic %K (14) | 5.43 | Buy |
| TRIX (15) | 0.28 | Buy |
| Awesome (5,34) | -0.03 | Sell |
| Ultimate (7,14,28) | 23.70 | Buy |
| Momentum (10) | -0.17 | Sell |
| Aroon Osc (25) | 28.00 | Buy |
| Hull MA (9) | 0.57 | Buy |
| ADX (14) | 13.90 | Neutral |
| ATR (14) | 0.02 | Info |
Near-term technicals show a bearish tone. The stock is trading below the SMA50 of $0.6263 and far below the SMA200 of $1.08, while the RSI(14) sits at 40.
Key support and resistance are at $0.552 and $0.764, respectively, and the 30-day trading range runs from $0.4533 to $0.7865.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.537 | $0.5899 | $0.8712 | 0% | Neutral | |
| $0.5002 | $0.674 | $0.979 | +14% | Neutral | |
| $0.5764 | $0.8155 | $1.25 | +38% | Bullish | |
| $0.5699 | $0.8407 | $1.34 | +43% | Bullish | |
| $0.4905 | $0.7513 | $1.24 | +27% | Bullish | |
| $0.4848 | $0.769 | $1.31 | +30% | Bullish | |
| $0.4277 | $0.7014 | $1.23 | +19% | Neutral | |
| $0.4734 | $0.8013 | $1.44 | +36% | Bullish | |
| $0.6224 | $1.09 | $2.00 | +84% | Bullish | |
| $0.5547 | $0.9971 | $1.87 | +69% | Bullish | |
| $0.6439 | $1.33 | $2.73 | +126% | Bullish | |
| $0.8346 | $1.85 | $4.27 | +214% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $0.537 | $0.5899 | $0.6925 | +0.00% |
| June 2026 | $0.4811 | $0.5732 | $0.7053 | -2.83% |
| July 2026 | $0.5018 | $0.6064 | $0.7626 | +5.80% |
| August 2026 | $0.5024 | $0.6141 | $0.7851 | +1.26% |
| September 2026 | $0.4875 | $0.6014 | $0.7794 | -2.06% |
| October 2026 | $0.5083 | $0.6325 | $0.8296 | +5.16% |
| November 2026 | $0.5335 | $0.6688 | $0.8865 | +5.74% |
| December 2026 | $0.5153 | $0.6508 | $0.8712 | -2.69% |
Click any year to see its month-by-month BMGL forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect BMGL to range from $0.537 to $0.8712 through 2026. The $0.5899 average target implies a 0% move from current prices. A consolidation phase looks the most probable path here.
The BMGL price prediction for 2027 points to an average of $0.674 (low $0.5002, high $0.979) — a potential gain of +14% on today's $0.5899. Price action looks broadly range-bound.
In 2028, BMGL is projected to trade between $0.5764 and $1.25, averaging $0.8155 — a potential gain of +38% from today's $0.5899. That is up +21% on the projected 2027 average. Buyers look set to stay in control over this stretch.
Basel Medical Group Ltd's 2029 outlook centres on $0.8407, within a $0.5699 to $1.34 range. That is up +3% on the projected 2028 average. That marks a +43% change versus current levels. Momentum favours further upside here.
By 2030, BMGL could reach as high as $1.24, with a base case around $0.7513 and support toward $0.4905 — roughly +27% from $0.5899. Buyers look set to stay in control over this stretch.
Expect BMGL to range from $0.4848 to $1.31 through 2031. The $0.769 average target implies a +30% move from current prices. That is up +2% on the projected 2030 average. Momentum favours further upside here.
The BMGL price prediction for 2032 points to an average of $0.7014 (low $0.4277, high $1.23) — a potential gain of +19% on today's $0.5899. A consolidation phase looks the most probable path here.
In 2033, BMGL is projected to trade between $0.4734 and $1.44, averaging $0.8013 — a potential gain of +36% from today's $0.5899. That is up +14% on the projected 2032 average. Momentum favours further upside here.
Basel Medical Group Ltd's 2034 outlook centres on $1.09, within a $0.6224 to $2.00 range. That is up +36% on the projected 2033 average. That marks a +84% change versus current levels. Buyers look set to stay in control over this stretch.
By 2035, BMGL could reach as high as $1.87, with a base case around $0.9971 and support toward $0.5547 — roughly +69% from $0.5899. Momentum favours further upside here.
Expect BMGL to range from $0.6439 to $2.73 through 2040. The $1.33 average target implies a +126% move from current prices. That is up +34% on the projected 2035 average. Buyers look set to stay in control over this stretch.
The BMGL price prediction for 2050 points to an average of $1.85 (low $0.8346, high $4.27) — a potential gain of +214% on today's $0.5899. Momentum favours further upside here.
Investing $1,000 in BMGL today (≈ 1,695.202577 BMGL) could be worth
$3,144.15
+$2,144.15 (+214%) by 2050 · US Dollar
Based on the average projected BMGL price of $1.85 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in BMGLwould be worth at today's price.
$1,000 invested in BMGL on May 27, 2025 (≈ 925.925889 BMGL) would be worth
$546.2
-$453.8 (-45.4%) today · 0.55× · US Dollar
Based on a BMGL entry price of $1.08 vs. today's $0.5899.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.645 | $914.57 | -8.5% |
| 1 month ago | $0.61 | $967.05 | -3.3% |
| 3 months ago | $0.62 | $951.45 | -4.9% |
| 6 months ago | $1.19 | $495.71 | -50.4% |
| 1 year ago | $1.08 | $546.2 | -45.4% |
| All time (1.2y) ago | $4.44 | $132.86 | -86.7% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our BMGL forecast.
Our base-case forecast reaches $1.20 around 2040.
Implied market cap at $1.20: $22.54M
The multi-year forecast paints a bullish growth path, with the average price rising over time. In 2026 the avg is $0.5971, in 2027 it is $0.6921, and in 2028 it is $0.8374, with 2030 at $0.7702 and 2050 at $1.87.
Notable upside appears in later years, with 2034 avg $1.12 and max $2.10, 2040 avg $1.37 and max $2.87, and 2050 avg $1.87 and max $4.30. ROI figures rise accordingly to 87.5 in 2034, 130.1 in 2040, and 213.1 in 2050, with other years showing varying but often bullish momentum.
Sentiment shifts across years, including Neutral in 2026 and 2032 and Bullish in 2027–2031, 2033–2035, 2040, and 2050, reflecting a trajectory of rising expectations alongside periods of steadier outlooks. While these are estimates and not guarantees, the longer-term view suggests meaningful upside potential.
Tap a question to reveal the answer.
2030 min $0.4936; avg $0.7702; max $1.30; ROI 29; sentiment BULLISH.
The forecast shows neutral in 2026 (avg $0.5971) with ROI 0 and neutral sentiment, followed by bullish periods in 2027–2031, 2033–2035, 2040, and 2050, with rising averages and ROI up to 213.1 by 2050.
Yes. The forecast max prices include $2.10 in 2034, $2.87 in 2040, and $4.30 in 2050.
The current price is $0.5971 and the market capitalization is $11.22M. The rank is 5123.
Bearish sentiment with RSI(14) 40; SMA50 $0.6263; SMA200 $1.08; support $0.552; resistance $0.764; 30-day range from $0.4533 to $0.7865.
Basel Medical Group Ltd Community Discussion
0Share your Basel Medical Group Ltd price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.